Learn about idiopathic pulmonary fibrosis, its symptoms, diagnosis, and treatment options for managing this lung disease.
Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following a prespecified data review and recommendation by the ...
The UK IPF Registry has provided new insights into the evolving landscape of idiopathic pulmonary fibrosis management.
The new chief medical officer of the Pulmonary Fibrosis Foundation speaks about patients in rural areas, research ...
Idiopathic pulmonary fibrosis (IPF) and diabetes mellitus do not appear to have a causal association, according to study findings published in Thorax.
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...
The following is a summary of "Quality of life in idiopathic pulmonary fibrosis in Latin American countries," published in ...
The trial, dubbed BEACON-IPF, was assessing the biotech’s lead candidate, an oral small molecule called bexotegrast. The ...
News Medical on MSN4d
Health organizations collaborate to address idiopathic pulmonary fibrosis on Rare Disease Day 2025The American College of Chest Physicians (CHEST), the PF Warriors, the Rare Disease Diversity Coalition (RDDC)-a program at the Black Woman's Health Imperative-and the National Association of ...
Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following a prespecified data review and recommendation by the trial's independent ...
An international team of researchers has, for the first time, created a detailed map of the location and identity of individual cells in the adult lung, both from healthy lungs and in lungs from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback